Sign up to our newsletter Subscribe
Delivering the 2.4 Percent: Unlocking UK Pharma R&D Investment through Evidence-Based Policies

We have established an excellent reputation for leading innovative, ideas-driven, and theoretically sound research on the measurement and valuation of outcomes. Health care systems should put patient-relevant outcomes at the heart of decisions about funding and providing health and social care.